# A Study of Efficacy and Safety of GenSci048 in Subjects With Active Uveitis.

> **NCT07547995** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Changchun GeneScience Pharmaceutical Co., Ltd.** · enrollment: 111 (estimated)

## Conditions studied

- Uveitis

## Interventions

- **DRUG:** GenSci048 High-dose
- **DRUG:** GenSci048 Low-dose
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07547995
- **Lead sponsor:** Changchun GeneScience Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-18
- **Primary completion:** 2027-12-14
- **Final completion:** 2028-01-13
- **Target enrollment:** 111 (ESTIMATED)
- **Last updated:** 2026-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07547995

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07547995, "A Study of Efficacy and Safety of GenSci048 in Subjects With Active Uveitis.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07547995. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*